COVID-19 vaccine development and a potential nanomaterial path forward

MD Shin, S Shukla, YH Chung, V Beiss… - Nature …, 2020 - nature.com
The COVID-19 pandemic has infected millions of people with no clear signs of abatement
owing to the high prevalence, long incubation period and lack of established treatments or …

[HTML][HTML] Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

L Galluzzi, I Vitale, S Warren, S Adjemian… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune
response associated with immunological memory, provided they display sufficient …

Calreticulin and cancer

J Fucikova, R Spisek, G Kroemer, L Galluzzi - Cell research, 2021 - nature.com
Calreticulin (CALR) is an endoplasmic reticulum (ER)-resident protein involved in a
spectrum of cellular processes. In healthy cells, CALR operates as a chaperone and Ca2+ …

Antitumour dendritic cell vaccination in a priming and boosting approach

A Harari, M Graciotti, M Bassani-Sternberg… - Nature Reviews Drug …, 2020 - nature.com
Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …

Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches

S Parvizpour, MM Pourseif, J Razmara, MA Rafi… - Drug Discovery …, 2020 - Elsevier
Highlights•Epitope vaccines provide maximal therapeutic efficacy with minimal side
effects.•Reverse vaccinology can be used for designing epitope vaccines.•Computational …

Non-mutational neoantigens in disease

LJ Stern, C Clement, L Galluzzi, L Santambrogio - Nature immunology, 2024 - nature.com
The ability of mammals to mount adaptive immune responses culminating with the
establishment of immunological memory is predicated on the ability of the mature T cell …

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

AJ Stephens, NA Burgess-Brown, S Jiang - Frontiers in immunology, 2021 - frontiersin.org
Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune
response to elicit its effector function. They have shown to be highly specific and safe, but …

Beneficial autoimmunity improves cancer prognosis

L Zitvogel, C Perreault, OJ Finn… - Nature Reviews Clinical …, 2021 - nature.com
Many tumour antigens that do not arise from cancer cell-specific mutations are targets of
humoral and cellular immunity despite their expression on non-malignant cells. Thus, in …

Liposomes for oral delivery of protein and peptide-based therapeutics: Challenges, formulation strategies, and advances

A Jash, A Ubeyitogullari, SSH Rizvi - Journal of Materials Chemistry B, 2021 - pubs.rsc.org
Throughout the past decade, there has been a rapid growth in the development of
protein/peptide-based therapeutics. These therapeutics have found widespread applications …

Immune cell-derived extracellular vesicles–new strategies in cancer immunotherapy

P Yang, Y Peng, Y Feng, Z Xu, P Feng, J Cao… - Frontiers in …, 2021 - frontiersin.org
Immune cell-derived extracellular vesicles (EVs) have increasingly become the focus of
research due to their unique characteristics and bioinspired applications. They are lipid …